Scientists have developed mathematical models that act as patient ‘surrogates’ for evaluating potential prostate cancer treatments.
Category: Uncategorized
Lilly’s tirzepatide doesn’t necessarily top diabetes rivals Jardiance and Ozempic, ICER says fkansteiner Wed, 02/16/2022 – 11:57
3 more deaths among patients on Biogen’s Aduhelm fuel safety concerns, though no link established: analyst kdunleavy Wed, […]
A reduced risk of infection and, as a consequence, a decrease in new infections are goals that have […]
An interim analysis of an ongoing Phase III study from UCLA Jonsson Comprehensive Cancer Center indicates that using […]
Grace (not her real name) is a primary school teacher in Malawi.1 She was also a university student, […]
Wordle and medicine some similarities. They both have their own cliques, warrant a certain pattern of thinking, and […]
How can pharma avoid HCP ‘promo fatigue’? With synchronized campaigns and storytelling nmissakian Tue, 02/15/2022 – 14:31
Moderna plots 4 new Asia branches, local hiring spree to build its commercial footprint for life beyond COVID […]
